Medication info
Rabemax Tablets 20 mg (Rabeprazole Sodium)

Rabemax Tablets 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Boryung Co., Ltd.
Appearance
Light yellow, round, enteric-coated tablet
Packaging
28 tablets (14 tablets/AluAlu packaging x 2)
Approval status
Active

MFDS item code 201500211 · Approved 2015.01.15 · Insurance code 641906210

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including combination therapy for eradication), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended that this medicine 20 mg be administered concomitantly with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose is administered in two divided doses of 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Ingredients

Manufacturer
Boryung Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including combination therapy for eradication), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease symptoms
  • Helicobacter pylori infection-related digestive ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective in the treatment of ulcers that occur in the stomach and duodenum. It also helps relieve uncomfortable symptoms caused by gastroesophageal reflux disease and maintain a stable condition for a long time after treatment. For patients with digestive ulcers infected with Helicobacter pylori, it enhances the treatment effect when combined with antibiotics. It is also used in conditions of excessive gastric acid secretion, such as Zollinger-Ellison syndrome. This medication is used for the treatment of various gastrointestinal related diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended that this medicine 20 mg be administered concomitantly with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose is administered in two divided doses of 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Precautions

This medication should not be used by certain patients. Do not take if you are allergic to this medication or its components, or have a hypersensitivity to specific antibiotics or other medications. Pregnant or breastfeeding women should also avoid using this medication. Patients with impaired liver function, elderly individuals, and those with a history of drug allergies should use this medication with caution. This medication contains certain dyes, so caution is required if you are allergic to these ingredients. If any allergic symptoms such as rash, hives, or itching occur while taking, discontinue use immediately. Regular blood tests are recommended as red blood cell or white blood cell counts may change. It is advisable to periodically check liver enzyme levels since this medication may affect liver function. Patients with heart disease should exercise caution as it may affect the heart and blood vessels. Digestive symptoms such as diarrhea, abdominal pain, and nausea may occur, and unusual symptoms should be reported. Neurological symptoms such as headache, dizziness, and insomnia may also occur. Various side effects, including respiratory symptoms, skin rash, and hair loss, have been reported. This medication may increase the risk of bone fractures with long-term use, so caution is needed. Hypomagnesemia may occur rarely, so it is advisable to monitor blood magnesium levels with long-term use. This medication reduces gastric acid secretion, which may slightly increase the risk of gastrointestinal infections. Be cautious of drowsiness when driving or operating machinery. There may be interactions with other medications, so be sure to inform your doctor if you are taking other medications. It is safer not to use this medication during pregnancy or breastfeeding. Elderly patients may be at risk for side effects due to declining liver function, so they should consult a healthcare professional if symptoms occur. Safety in children has not been established, and use is not recommended. There is no specific antidote for overdose, so appropriate treatment according to symptoms is necessary. This medication should be swallowed whole and not chewed or crushed. Keep out of reach of children, and do not transfer to another container. Regular examinations and monitoring as directed by a doctor are necessary with long-term use.

Side effects

Rash, hives, itching, decreased red blood cells, decreased white blood cells, increased white blood cells, increased eosinophils, increased neutrophils, decreased lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, atrioventricular block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, hyperphagia, abnormal stools, colitis, esophagitis, stomatitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, oral mucositis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, neurohyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, weakness of the limbs, sensory loss, grip weakness, language confusion, staggering, confusion, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonia, neuralgia, focal muscle contraction, sweating, alopecia, skin dryness, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, increased urinary frequency, dysmenorrhea, difficulty urinating, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated thyroid-stimulating hormone, systemic lupus erythematosus, cutaneous lupus erythematosus, Clostridium difficile-associated diarrhea, halitosis, dry mouth, increased intraocular pressure, palpitations, facial edema, flushing, paresthesia, confusion, weakness, anxiety, insomnia, drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1°C and 30°C. By storing it this way, the effectiveness of the medication can be safely maintained.

Appearance and packaging

Appearance

Light yellow, round, enteric-coated tablet

Package unit

28 tablets (14 tablets/AluAlu packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.